Join Now

Category Archives: BioUtah News

University of Manchester Adds Carterra’s LSA® Instrument for High-Throughput Antibody Screening and Characterization

By admin | Published June 9, 2022

MANCHESTER, England & SALT LAKE CITY–(BUSINESS WIRE)–The University of Manchester, United Kingdom, and Carterra, Inc., the world leader in innovative technologies enabling high-throughput biology, announced today that the University of Manchester has added Carterra’s LSA instrument to its Biomolecular Analysis Core Facility (BACF) within the Faculty of Biology, Medicine and Health (FBMH). The BACF was […]

| Leave a comment

Sumitomo Pharma Oncology Receives Orphan Drug Designation for TP-3654, an Investigational Oral Inhibitor of PIM Kinases for the Treatment of Myelofibrosis

By admin | Published June 9, 2022

CAMBRIDGE, Mass., June 8, 2022 /PRNewswire/ — Sumitomo Pharma Oncology, Inc., a clinical-stage company focused on novel cancer therapeutics, today announced the U.S. Food Drug and Administration (FDA) granted Orphan Drug Designation for TP-3654, the company’s proprietary investigational oral inhibitor of PIM kinases, for the treatment of myelofibrosis. “This designation is an important milestone in […]

| Leave a comment

ELEVAR THERAPEUTICS SHARES RESULTS OF PHASE 2 RIVOCERANIB TRIAL IN PATIENTS WITH PROGRESSIVE RECURRENT OR METASTATIC ADENOID CYSTIC CARCINOMA

By admin | Published June 9, 2022

CHICAGO, June 06, 2022 — Elevar Therapeutics, Inc., a fully integrated biopharmaceutical company dedicated to elevating treatment experiences and outcomes for patients who have limited or inadequate therapeutic options, today detailed the results of its Phase 2 clinical trial (Study RM-202) of rivoceranib, an orally administered tyrosine kinase inhibitor (TKI), in patients with progressive recurrent […]

| Leave a comment

CerTest Biotec and BD Announce Collaboration on Molecular Diagnostic Test for Monkeypox

By Natalie Themm | Published June 8, 2022

CerTest Biotec Uses the BD MAX™ Molecular Diagnostic System Open System Reagent Suite to Develop RT-PCR Detection Kit

| Tagged | Leave a comment

BD TO ACQUIRE PARATA SYSTEMS TO ENTER NEW PHARMACY AUTOMATION SOLUTIONS MARKET

By Natalie Themm | Published June 7, 2022

Expands BD Transformative Solutions to Provide New Pharmacy Automation Technologies for Hospitals, Retail Pharmacy, Long-Term Care and Home Settings Advances BD 2025 Strategy to Accelerate Innovation in Smart, Connected Care and Enable New Care Settings Expected to be Immediately Accretive to Revenue Growth, Adjusted Operating Margins and Adjusted EPS; Enhances Ability to Achieve Long-Range Sales […]

| Tagged | Leave a comment

KidneyIntelX™ Demonstrates Ability to Assess Risk of Heart Failure Hospitalization and Death in Large International Diabetic Kidney Disease Patient Cohort

By Natalie Themm | Published June 6, 2022

Data shared in oral presentation at American Diabetes Association 82nd Scientific Sessions® and published in Kidney360 highlights importance in early understanding of cardiovascular risk, a leading cause of death in patients with diabetes and chronic kidney disease

| Tagged | Leave a comment

PolarityTE Announces $8.0 Million Registered Direct and Private Placement Offerings Priced At-The-Market Under Nasdaq Rules

By Natalie Themm | Published June 6, 2022

PolarityTE announced that it has entered into securities purchase agreements with a single healthcare-focused institutional investor

| Tagged | Leave a comment

Civica Selects Profil as Clinical Trial Partner for Affordable Insulin Initiative

By Natalie Themm | Published June 6, 2022

Profil has conducted over 30 biosimilar insulin trials and is the leading clinical research organization for studies related to diabetes.

| Tagged | Leave a comment

Biomerics announces expansion in Ireland with a new facility in Galway

By Natalie Themm | Published May 31, 2022

BIOMERICS ANNOUNCES EXPANSION INTO IRELAND Expanding High-Performance Balloon Design & Development Capabilities in Galway

| Tagged | Leave a comment

Co-Diagnostics, Inc. Completes Principal Design of Test for Monkeypox Virus

By Natalie Themm | Published May 31, 2022

Co-Diagnostics announced that it has completed the principal design work of a PCR test for the monkeypox virus currently exhibiting a multi-country outbreak.

| Tagged , | Leave a comment

Biomerics Announces Image Guided Intervention Division

By admin | Published May 26, 2022

SALT LAKE CITY, UTAH (Monday, May 2, 2022) – Biomerics, a leading vertically integrated contract manufacturer for the attractive interventional device market, announced the creation of a new division, Biomerics Image Guided Intervention (IGI). Biomerics’ IGI Division, headquartered in Salt Lake City, provides advanced image generation and processing technologies to enable real-time minimally invasive advanced […]

| Leave a comment

bioMérieux receives De Novo FDA Authorization for its BIOFIRE® Joint Infection (JI) Panel

By Natalie Themm | Published May 25, 2022

Marcy l’Étoile, France – bioMérieux, a world leader in the field of in vitro diagnostics, today announces that its BIOFIRE® Joint Infection (JI) Panel has received De Novo authorization from the US Food and Drug Administration (FDA). This panel tests for 31 pathogens implicated in most acute joint infections, and also includes 8 antimicrobial resistance (AMR) […]

| Tagged | Leave a comment

A Special Thanks To Our Legacy and Platinum Elite Members